Knowledge Ecology International
Attending and mending the knowledge ecosystem
Menu Close
  • About
  • Areas of work
  • Coronavirus
  • Xtandi
  • Listserves
  • Videos
  • Publications
  • Databases
  • Donate
Home»Blogs»NIH wants to give Gilead a new, government subsidized monopoly on CAR T technology, this one for CD-30 proteins.

NIH wants to give Gilead a new, government subsidized monopoly on CAR T technology, this one for CD-30 proteins.

Posted on January 5, 2018 by James Love

We have a briefing note on this license here: 2018: Briefing note on NIH proposed license to Gilead for CD-30 CAR T technology

Access to Medicine CAR T, cd-30, Gilead, kite, NIH

Post navigation

2018: Briefing note on NIH proposed license to Gilead for CD-30 CAR T technology
Expert Panel charts a road map for WHO’s engagement on transparency and R&D

Categories

  • About
  • Access to Knowledge
  • Access to Medicine
  • AI
  • Competition
  • Delinkage
  • Economics
  • Events
  • Evidence
  • Government Funded research
  • influence
  • Intellectual Property Rights
  • Legislation
  • Litigation
  • Lobbying
  • Marketing
  • Meetings
  • Negotiations
  • Nuclear Proliferation
  • Orphan Drugs
  • Presentations
  • Privacy
  • Public Goods
  • Research and Development
  • Site Articles
  • Timelines
  • Trade
  • Transparency
  • WHO
  • WIPO
  • WTO
© 2024 Knowledge Ecology International. All rights reserved.
Hiero by aThemes